Search

everythinglearnresearchcommunity

for

Search:↓

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The document concludes that new treatments are needed to better manage acne and reduce side effects related to current therapies.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

In vivo lineage labelling is better than in vitro methods for identifying and understanding stem cells.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Glypican-1 is important for blood vessel growth in hair follicles and could help treat hair loss.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

A circular RNA helps cashmere goat hair cells become hair follicles by blocking a molecule to boost a gene important for hair growth.

N-acetyl-L-cysteine (NAC) can prevent DNA damage and protect cells from harm.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

The research suggests that p63 and TGF-β1 may help determine tumor type and malignancy in hair follicle and sebaceous tumors.

Glioblastoma cells can make androgens, which might help the tumor grow.

Lymphatic vessels are essential for health and can be targeted to treat various diseases.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Annexin A2 isoform 2 helps dermal papillae cells grow, affecting hair growth.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Fish oil improves skin health in people with diabetes and high cholesterol.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

A group has developed therapies that show promise for treating cancer and various other conditions.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.